WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
BBIO
BRIDGEBIO PHARMA INC
$5.21BN/A-84.30%-64.08%-25.30%-1.805.5498.90%-246.20%-207.52%
TPST
TEMPEST THERAPEUTICS INC
$81.89M-283.90%-82.10%-66.46%-107.20%0.934.29N/AN/AN/A
BHVN
BIOHAVEN LTD
$3.32B-103.50%-80.80%-89.46%-163.40%0.207.98N/AN/AN/A
ADVM
ADVERUM BIOTECHNOLOGIES INC
$216.47M-98.60%-52.80%-79.84%-73.90%1.074.13100.00%-3,254.60%-3,284.53%
CERE
CEREVEL THERAPEUTICS HOLDINGS INC
$7.73B-100.10%-44.50%-36.64%-37.00%0.8510.92N/AN/AN/A
CGTX
COGNITION THERAPEUTICS INC
$75.27M-83.50%-63.10%-103.07%1,689.50%0.443.37N/AN/AN/A
SNGX
SOLIGENIX INC
$4.26M-268.30%-53.40%-215.61%531.00%2.881.5511.60%-731.60%-936.36%
INBX
INHIBRX INC
$1.62B-590.80%-84.10%-83.28%-106.70%6.085.25100.00%-13,408.90%-11,639.89%
AIM
AIM IMMUNOTECH INC
$20.21M-118.30%-97.90%-269.94%-389.10%0.891.6879.20%-14,337.60%-14,337.62%
FRES
FRESH2 GROUP LTD
$4.50M-241.80%-104.10%-104.90%-370.80%0.720.4649.70%-1,058.70%-1,055.25%
REVB
REVELATION BIOSCIENCES INC
$3.87M-1.30%-0.80%-1.81%2.10%0.842.18N/AN/AN/A
TOVX
THERIVA BIOLOGICS INC
$6.91M-42.90%-29.30%-41.23%-101.70%0.424.07N/AN/AN/A
FHTX
FOGHORN THERAPEUTICS INC
$254.97MN/A-30.00%-41.41%-37.20%-4.704.11100.00%-288.20%-275.80%
SONN
SONNET BIOTHERAPEUTICS HOLDINGS INC
$5.71M-519.50%-169.50%-538.83%518.10%1.081.74100.00%-11,193.30%-11,193.30%
PROK
PROKIDNEY CORP
$504.56MN/A-7.70%-7.45%-11.60%-0.0314.94N/AN/AN/A
CGEN
COMPUGEN LTD
$186.56M-26.20%-17.40%-10.29%-34.00%0.854.3694.00%-56.10%-29.24%
TRVN
TREVENA INC
$7.57M-1,018.20%-98.90%-109.91%-500.00%-6.304.6646.60%-1,289.20%-1,162.46%
CYTK
CYTOKINETICS INC
$6.72BN/A-65.10%-69.00%-36.00%-3.136.12100.00%-6,988.60%-6,612.72%
CHRS
COHERUS BIOSCIENCES INC
$255.86MN/A-45.60%-66.39%-29.10%-4.261.4338.20%-92.50%-76.86%
MCRB
SERES THERAPEUTICS INC
$175.17MN/A-32.40%-38.68%-32.70%-8.991.78100.00%-90.00%-79.59%
CELU
CELULARITY INC
$63.75M-144.20%-62.20%-246.75%-148.00%4.200.20-25.00%-1,226.70%-1,210.73%
GYRE
GYRE THERAPEUTICS INC
$1.29BN/A-235.80%-87.49%-455.50%-2.412.8595.90%-81.90%-74.41%
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
$12.99M-649.30%-300.20%-416.32%-1,084.50%0.871.76N/AN/AN/A
NVCT
NUVECTIS PHARMA INC
$144.64M-144.80%-107.80%-182.44%450.60%0.572.75N/AN/AN/A
KYTX
KYVERNA THERAPEUTICS INC
$657.51MN/A-85.00%-108.75%-213.20%-0.203.06N/AN/AN/A
LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INC
$6.50M-129.70%-119.90%-126.94%3,275.50%0.0813.73N/AN/AN/A
KALV
KALVISTA PHARMACEUTICALS INC
$511.74M-86.10%-72.70%-114.19%-116.90%0.295.44N/AN/AN/A
PHIO
PHIO PHARMACEUTICALS CORP
$3.77M-134.70%-105.90%-140.05%886.70%0.215.71N/AN/AN/A
XTLB
XTL BIOPHARMACEUTICALS LTD
$13.79M-57.30%-53.90%N/A-151.20%0.09N/AN/AN/AN/A
AVBP
ARRIVENT BIOPHARMA INC
$526.68MN/A-40.10%-45.77%-1,096.90%-0.0813.76N/AN/AN/A
LCTX
LINEAGE CELL THERAPEUTICS INC
$199.85M-31.30%-19.90%-28.04%-285.40%0.622.1492.50%-240.20%-260.36%
ESLA
ESTRELLA IMMUNOPHARMA INC
$36.61M-690.30%-67.40%-92.43%285.80%0.0423.69N/AN/AN/A
RARE
ULTRAGENYX PHARMACEUTICAL INC
$3.55B-425.60%-45.90%-57.96%-78.00%8.322.4388.60%-138.60%-139.00%
CYBN
CYBIN INC
$143.93M-109.40%-98.20%-58.10%-7,001.60%0.075.76N/AN/AN/A
CALC
CALCIMEDICA INC
$61.65M-234.70%-165.70%-421.20%6,581.80%0.492.88N/AN/AN/A
NEXI
NEXIMMUNE INC
$4.55M-247.20%-167.40%-921.57%-3,024.20%1.451.06N/AN/AN/A
QNRX
QUOIN PHARMACEUTICALS LTD
$2.86M-105.10%-55.70%-101.15%-118.10%1.153.15N/AN/AN/A
ANRO
ALTO NEUROSCIENCE INC
$382.29MN/A-52.80%-43.12%-473.80%-0.2415.22N/AN/AN/A
OGEN
ORAGENICS INC
$4.79M-304.10%-246.90%-651.01%-2,094.20%0.572.15100.00%-54,858.10%-54,776.90%
IMUX
IMMUNIC INC
$123.20M-157.40%-117.40%-316.58%1,224.10%0.882.12N/AN/AN/A
APLM
APOLLOMICS INC
$35.53MN/A-261.80%-412.23%-1,989.50%0.342.95N/AN/AN/A
NBY
NOVABAY PHARMACEUTICALS INC
$2.86M-240.20%-126.70%-202.69%-177.50%1.731.6753.60%-113.40%-65.46%
NBSE
NEUBASE THERAPEUTICS INC
$1.51M-103.50%-62.40%-98.24%-149.20%1.042.87N/AN/AN/A
BOLD
BOUNDLESS BIO INC
N/AN/AN/A-41.01%N/A-0.0713.27N/AN/AN/A
NAMS
NEWAMSTERDAM PHARMA CO NV
$1.95B-45.80%-40.30%-59.53%514.30%0.206.95100.00%-1,255.80%-1,255.57%
VERU
VERU INC
$238.60M-214.40%-93.40%-97.58%-335.60%0.563.2150.30%-405.40%-391.66%
FBLG
FIBROBIOLOGICS INC
$261.73MN/A-229.00%-619.33%2,007.10%8.431.00N/AN/AN/A
VANI
VIVANI MEDICAL INC
$97.86M-87.20%-50.50%-64.01%-85.70%1.214.03N/AN/AN/A
MNMD
MIND MEDICINE (MINDMED) INC
$413.34M-93.30%-67.90%-103.72%473.10%0.593.22N/AN/AN/A
CARA
CARA THERAPEUTICS INC
$42.52M-122.10%-89.60%-117.61%-175.20%1.214.5470.60%-565.20%-562.33%
IMNN
IMUNON INC
$12.50M-98.00%-66.50%-141.79%-127.30%0.642.47N/AN/AN/A
ASMB
ASSEMBLY BIOSCIENCES INC
$72.10M-117.70%-72.40%-62.70%-144.80%2.333.41N/AN/AN/A
CNTX
CONTEXT THERAPEUTICS INC
$29.54M-115.50%-97.00%-201.87%1,198.10%0.353.83N/AN/AN/A
KOD
KODIAK SCIENCES INC
$197.96M-80.20%-46.20%-59.52%-105.60%0.806.93N/AN/AN/A
MNPR
MONOPAR THERAPEUTICS
$12.69M-116.00%-88.20%-150.37%-1,031.30%0.324.17N/AN/AN/A
INDP
INDAPTUS THERAPEUTICS INC
$17.25M-91.80%-80.40%-126.94%-314.20%0.245.05N/AN/AN/A
INAB
IN8BIO INC
$43.29M-147.70%-105.00%-105.97%-214.10%0.354.57N/AN/AN/A
PRTG
PORTAGE BIOTECH INC
$5.36M-232.80%-171.00%-367.80%-197.00%0.552.78N/AN/AN/A
ANL
ADLAI NORTYE LTD
$507.98MN/A-103.40%-129.50%-610.70%0.642.01100.00%-2,097.40%-2,068.74%
BIOR
BIORA THERAPEUTICS INC
$22.16MN/A-294.10%360.20%-184.90%-1.310.30100.00%-3,102,875.00%-2,859,750.00%
XRTX
XORTX THERAPEUTICS INC
$5.35M-97.20%-76.10%-128.95%-911.00%0.099.44N/AN/AN/A
SAVA
CASSAVA SCIENCES INC
$953.12M-57.50%-52.60%-70.72%-701.80%0.109.13N/AN/AN/A
TIL
INSTIL BIO INC
$73.49M-58.50%-41.60%-47.89%-35.50%0.4415.23N/AN/AN/A
BCDA
BIOCARDIA INC
$10.16M-3,638.70%-228.60%1,863.29%7,044.70%-2.860.41100.00%-2,425.80%-2,425.79%
VSTM
VERASTEM INC
$275.72M-127.00%-54.70%-67.48%-128.00%1.245.45N/AN/AN/A
SCPX
SCORPIUS HOLDINGS INC
$6.70M-101.40%-61.80%-109.95%-77.40%0.720.4760.90%-646.40%-643.50%
AGEN
AGENUS INC
$273.76MN/A-68.10%-254.82%-197.30%-2.880.4498.00%-157.40%-94.58%
PTCT
PTC THERAPEUTICS INC
$2.53BN/A-36.90%-41.41%-68.20%-3.002.0392.90%-62.40%-54.24%
VERA
VERA THERAPEUTICS INC
$2.37B-73.30%-50.80%-60.17%-66.10%0.737.71N/AN/AN/A
ADXN
ADDEX THERAPEUTICS LTD
$8.96M-276.20%-156.00%-584.31%1,054.30%3.051.46100.00%-640.90%-620.33%
SMMT
SUMMIT THERAPEUTICS INC
$3.08B-136.10%-55.50%-75.66%-52.20%3.006.97N/AN/AN/A
ALRN
AILERON THERAPEUTICS INC
$63.82M-139.40%-42.00%-15.48%-1,583.50%1.124.17N/AN/AN/A
XLO
XILIO THERAPEUTICS INC
$40.68M-126.60%-89.20%-169.90%-512.50%0.653.02N/AN/AN/A
AVTX
AVALO THERAPEUTICS INC
$14.85M-1,439.90%-113.90%-171.68%1,841.70%1.871.8233.30%-1,639.50%-1,461.17%
TSVT
2SEVENTY BIO INC
$244.24M-65.40%-32.80%-43.03%-29.80%1.223.9883.10%-216.70%-216.73%
AKBA
AKEBIA THERAPEUTICS INC
$286.84MN/A-20.60%-32.36%-73.30%-8.901.1861.90%-26.70%-23.58%
VAXX
VAXXINITY INC
$17.87M-192.60%-88.00%-210.58%-157.40%2.311.89N/AN/AN/A
MDGL
MADRIGAL PHARMACEUTICALS INC
$4.57B-219.40%-98.80%-69.14%-124.20%0.585.38N/AN/AN/A
KZIA
KAZIA THERAPEUTICS LTD
$7.17M-186.40%-60.10%-122.43%1,002.70%3.630.71100.00%-68,256.80%-69,438.83%
FGEN
FIBROGEN INC
$112.60MN/A-58.70%-130.52%-87.20%-2.871.5287.20%-192.40%-181.86%
EVAX
EVAXION BIOTECH A
$14.97M-1,238.10%-126.70%-365.79%-160.70%-3.731.18100.00%-30,308.20%-29,087.67%
GUTS
FRACTYL HEALTH INC
$311.69MN/A-137.50%-118.56%-112.10%-0.353.1935.80%-78,559.20%-64,242.50%
OMER
OMEROS CORP
$216.13M-1,290.70%-24.10%-26.76%-10.90%-16.144.09N/AN/AN/A
CSBR
CHAMPIONS ONCOLOGY INC
$69.74M-850.70%-32.60%-200.46%-94.90%-14.020.6040.10%-19.80%-19.62%
DARE
DARE BIOSCIENCE INC
$31.28MN/A-120.80%-3,761.81%222.90%-5.220.86100.00%-1,074.20%-1,074.17%
NCNA
NUCANA PLC
$8.46M-115.40%-72.80%-211.63%9,568.30%0.871.97N/AN/AN/A
ANEB
ANEBULO PHARMACEUTICALS INC
$76.50M-109.40%-98.40%-161.24%1,888.20%0.166.73N/AN/AN/A
WINT
WINDTREE THERAPEUTICS INC
$2.52M-275.10%-56.30%-71.25%-1,195.60%8.561.35N/AN/AN/A
BPTH
BIO-PATH HOLDINGS INC
$1.77M-375.70%-248.60%-1,223.59%-1,019.90%6.301.60N/AN/AN/A
VINC
VINCERX PHARMA INC
$18.78M-187.70%-126.30%-318.40%-246.50%0.622.63N/AN/AN/A
GLPG
GALAPAGOS NV
$1.92BN/AN/AN/AN/A0.519.91N/AN/AN/A
CERO
CERO THERAPEUTICS HOLDINGS INC
$20.32MN/A-22.30%-72.08%-30.40%-1.011.66N/AN/AN/A
TELO
TELOMIR PHARMACEUTICALS INC
$183.58M-1,045.40%-542.10%-332.41%-879.40%0.393.57N/AN/AN/A
FWBI
FIRST WAVE BIOPHARMA INC
$5.27M-614.80%-284.10%-420.61%1,616.00%0.911.58N/AN/AN/A
CTCX
CARMELL CORP
$42.34M-1,325.20%-38.10%-57.34%-149.80%1.581.63N/AN/AN/A
GRI
GRI BIO INC
$1.31M-795.50%-345.40%-4,229.73%855.50%10.411.09N/AN/AN/A
PHGE
BIOMX INC
$21.20M-242.00%-74.40%-171.39%-152.30%7.121.58N/AN/AN/A
MYMD
MYMD PHARMACEUTICALS INC
$7.18M-63.60%-35.20%-31.07%-47.40%0.411.17N/AN/AN/A
MBIO
MUSTANG BIO INC
$3.30M-433.10%-146.40%-2,003.08%-578.20%143.240.74N/AN/AN/A
RGLS
REGULUS THERAPEUTICS INC
$173.48M-109.20%-80.60%-132.33%-893.20%0.453.31N/AN/AN/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Corcept Therapeutics (NASDAQ:CORT)


Corcept Therapeutics (NASDAQ:CORT) is the top biotech stock with a Zen Score of 65, which is 42 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 6.15% over the past year, overperforming other biotech stocks by 24 percentage points.

Corcept Therapeutics has an average 1 year price target of $40.67, an upside of 65.85% from Corcept Therapeutics's current stock price of $24.52.

Corcept Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Corcept Therapeutics, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the second best biotech stock with a Zen Score of 64, which is 41 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -20.99% over the past year, underperforming other biotech stocks by -3 percentage points.

Incyte has an average 1 year price target of $74.92, an upside of 39.37% from Incyte's current stock price of $53.76.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 30.77% have issued a Strong Buy rating, 23.08% have issued a Buy, 46.15% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third best biotech stock with a Zen Score of 63, which is 40 points higher than the biotech industry average of 23. It passed 20 out of 33 due diligence checks and has strong fundamentals. Amylyx Pharmaceuticals has seen its stock lose -92.77% over the past year, underperforming other biotech stocks by -74 percentage points.

Amylyx Pharmaceuticals has an average 1 year price target of $11.00, an upside of 441.87% from Amylyx Pharmaceuticals's current stock price of $2.03.

Amylyx Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Amylyx Pharmaceuticals, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 3 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)


Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 42 percentage points higher than the biotech industry average of 15.03%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk A S (NYSE:NVO)


Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.11%, which is -14 percentage points lower than the biotech industry average of 15.03%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% eight times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 47.8% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.41%, which is -15 percentage points lower than the biotech industry average of 15.03%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 22.7% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.07% in the last day, and up 6% over the last week. Ardelyx was the among the top gainers in the biotechnology industry, gaining 28.42% yesterday.

Ardelyx shares are trading higher after the company reported better-than-expected Q1 financial results.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Incyte (NASDAQ:INCY)


Incyte (NASDAQ:INCY) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -20.99% in the past year. It has underperformed other stocks in the biotech industry by -3 percentage points.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 86, which is 73 points higher than the biotech industry average of 13. It passed 6 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -19.61% in the past year. It has underperformed other stocks in the biotech industry by -1 percentage points.

3. Amylyx Pharmaceuticals (NASDAQ:AMLX)


Amylyx Pharmaceuticals (NASDAQ:AMLX) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Amylyx Pharmaceuticals has a valuation score of 71, which is 58 points higher than the biotech industry average of 13. It passed 5 out of 7 valuation due diligence checks.

Amylyx Pharmaceuticals's stock has dropped -92.77% in the past year. It has underperformed other stocks in the biotech industry by -74 percentage points.

Are biotech stocks a good buy now?

50.1% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 80.46% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 6.05x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.